Imai S, Haga S, Kiyozuka Y
Nara Prefectural Institute of Public Health, Japan.
Tumour Biol. 1998;19 Suppl 1:30-4. doi: 10.1159/000056502.
The 56 MAbs submitted to the ISOBM TD-4 Workshop were analysed by ELISA assay for reactivity against synthetic MUC1 mucin protein core-related peptides. With peptides comprising 5, 7 and 20 amino acids, 4/56 (7.1%), 33/56 (58.9%) and 51/56 (91.1%) of antibodies showed positive reactivity, respectively. Peptides with 60, 80, 100 and 120 amino acids showed 50/56 (98.2%), 54/56 (96.4%), 53/56 (94.6%) and 47/56 (83.9%) antibodies with positive reactivity, respectively. The reactivity of each MAb with synthetic peptides was classified into 3 groups. In group A (15 MAbs), the reactivity increased depending on the peptides in length and was maximal with 20-, 60-, 80-, 100- and 120-mer peptides. In group B (24 MAbs), most antibodies showed very weak binding affinity to peptides with a small increase in reactivity with the 100- and 120-mer peptides. In group C (17 MAbs), the reactivity showed strong binding affinity with the 20-mer peptide followed by a reduced uneven pattern of reactivity with the 60-, 80-, 100- and 120-mer peptides. These results show that the binding affinity of MAbs against synthetic peptides does not depend on the recognition of antibodies to the epitopes of core protein.
通过ELISA分析了提交给ISOBM TD - 4研讨会的56种单克隆抗体(MAb)与合成MUC1粘蛋白核心相关肽的反应性。对于包含5、7和20个氨基酸的肽,分别有4/56(7.1%)、33/56(58.9%)和51/56(91.1%)的抗体显示出阳性反应性。含有60、80、100和120个氨基酸的肽分别有50/56(98.2%)、54/56(96.4%)、53/56(94.6%)和47/56(83.9%)的抗体呈现阳性反应性。每种单克隆抗体与合成肽的反应性分为3组。在A组(15种单克隆抗体)中,反应性随肽长度增加而增强,在20肽、60肽、80肽、100肽和120肽时达到最大。在B组(24种单克隆抗体)中,大多数抗体对肽的结合亲和力非常弱,与100肽和120肽反应性略有增加。在C组(17种单克隆抗体)中,与20肽反应性显示出强结合亲和力,随后与60肽、80肽、100肽和120肽反应性呈降低且不均匀的模式。这些结果表明,单克隆抗体与合成肽的结合亲和力并不取决于抗体对核心蛋白表位的确识。